Key Segmentation:
By Product Type
-
Therapeutic Devices
-
Diagnostic and Monitoring Devices
-
Consumables and Accessories
By Therapeutic Device Type
-
PAP Devices
-
Ventilators
-
Humidifiers
-
Oxygen Concentrators
-
Nebulizers
By Disease Indication
-
Chronic Obstructive Pulmonary Disease
-
Asthma
-
Sleep Apnea
-
Infectious Disease
-
Other Respiratory Disorders
By End User
-
Hospitals
-
Home Care Settings
-
Ambulatory Surgical Centers
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Koninklijke Philips N.V., Medtronic plc, ResMed Inc., GE HealthCare Technologies Inc., and Dragerwerk AG & Co. KGaA, among other medical device manufacturers.
Continued expansion of home-based respiratory therapy and continued development of AI-enabled therapy personalisation represent the primary opportunities.
Growth is primarily driven by the increasing global prevalence of respiratory diseases, combined with continued digital health and artificial intelligence innovation.
By Product Type, Therapeutic Devices dominated the market with a 52.35% share in 2025, reflecting sustained demand for CPAP machines, ventilators, and oxygen concentrators.
North America dominated the market with a 37.65% share in 2025, supported by robust healthcare systems and deep public awareness of respiratory health.